Ogilvie syndrome 1 K59.81 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. 2 ICD-10-CM K59.81 is a new 2021 ICD-10-CM code that became effective on October 1, 2020. 3 This is the American ICD-10-CM version of K59.81 - other international versions of ICD-10 K59.81 may differ.
There may also be nausea and vomiting. Ogilvie syndrome may occur after surgery, especially following coronary artery bypass surgery and total joint replacement. Drugs that disturb colonic motility (such as anticholinergics or opioid analgesics) contribute to the development of this condition.
Ogilvie syndrome is not the same as chronic intestinal pseudo-obstruction. The syndrome is due to nerve or muscle problems that affect peristalsis (involuntary, rhythmic muscular contractions) within the colon. Although the symptoms mimic those of mechanical blockage of the colon, no such physical obstruction is present.
Gilbert syndrome Gilbert's syndrome; Gilberts syndrome ICD-10-CM Diagnosis Code E24.1 [convert to ICD-9-CM]
81) and other specified functional intestinal disorders (K59. 89). Ogilvie syndrome, also referred to as acute colonic ileus and acute colonic pseudo-obstruction (ACPO), is an uncommon condition that affects the large intestines.
Diagnosis of Ogilvie's syndrome is based on clinical and radiologic grounds, and can be treated conservatively or with interventions such as acetylcholinesterase inhibitors (such as neostigmine), decompressive procedures including colonoscopy, and even surgery.
Functional intestinal disorder, unspecified The 2022 edition of ICD-10-CM K59. 9 became effective on October 1, 2021. This is the American ICD-10-CM version of K59. 9 - other international versions of ICD-10 K59.
Abdominal and pelvic pain Painful sensation in the abdominal region. Sensation of discomfort, distress, or agony in the abdominal region; generally associated with functional disorders, tissue injuries, or diseases. ICD-10-CM R10. 9 is grouped within Diagnostic Related Group(s) (MS-DRG v39.0):
DEFINITION. Acute colonic pseudo-obstruction (Ogilvie's syndrome) is a disorder characterized by acute dilatation of the colon in the absence of an anatomic lesion that obstructs the flow of intestinal contents. ETIOLOGY.
The use of certain medications has also been associated with the development of Ogilvie syndrome including neuroleptic medications, anticholinergics, amphetamines, steroids and narcotics. Ogilvie syndrome most likely results from abnormalities affecting the autonomic nervous system's control of colonic motor function.
Dysmotility is a condition in which muscles of the digestive system become impaired and changes in the speed, strength or coordination in the digestive organs occurs. In the normal small intestine, liquefied food and secretions including digestive enzymes are pushed onwards by waves of muscular contraction.
Esophageal motility refers to contractions occurring in the esophagus, which propel the food bolus forward toward the stomach. When contractions in the esophagus become irregular, unsynchronized or absent, the patient is said to have esophageal dysmotility.
ICD-10-CM Code for Gastroparesis K31. 84.
R10. 9 - Unspecified abdominal pain. ICD-10-CM.
ICD-10-CM Code for Lower abdominal pain, unspecified R10. 30.
9: Fever, unspecified.
The high rate is likely a measure that this syndrome is seen in critically ill patients, rather than this syndrome being in itself lethal, although it can also present in otherwise healthy individuals (especially if the disorder was induced by pharmacologic agents). Drug induced megacolon (such as from clozapine) has been associated with mortality as high as 27.5%.
Acute megacolon develops because of abnormal intestinal motility. Normal colonic motility requires integration of myogenic, neural, and hormonal influences.
Ogilvie syndrome may occur after surgery, especially following coronary artery bypass surgery and total joint replacement. Drugs that disturb colonic motility (such as anticholinergics or opioid analgesics) contribute to the development of this condition.
Clinical features can include abdominal pain, nausea, severe distension, vomiting, dysphagia, diarrhea and constipation, depending upon the part of the gastrointestinal tract involved. The condition can begin at any age and it can be a primary condition (idiopathic or inherited) or caused by another disease (secondary). Specialty:
Intestinal pseudo-obstruction is a clinical syndrome caused by severe impairment in the ability of the intestines to push food through. It is characterised by the signs and symptoms of intestinal obstruction without any lesion in the intestinal lumen. Clinical features can include abdominal pain, nausea, severe distension, vomiting, dysphagia, diarrhea and constipation, depending upon the part of the gastrointestinal tract involved. The condition can begin at any age and it can be a primary condition (idiopathic or inherited) or caused by another disease (secondary).